Clinical Trial Update: Investigation of the Response Relationship of NN5401 in Type 1 Diabetics [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating NN5401 in people with Type 1 diabetes mellitus has completed, according to sponsor Novo Nordisk A/S.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• NN5401

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED